ENVALITH
アース製薬株式会社 logo

Earth Corporation

4985Prime MarketChemicals

アース製薬株式会社 logo
Earth Corporation4985
Reference Indicators

Market Cap

1,038¥100M

P/E (Forecast)

P/B

1.4x

Dividend Yield (Forecast)

2.78%

ROE

7.3%

EV/EBITDA

6.9x
Financial Summary
Unit: ¥M
Item
2021Dec 2021
2022Dec 2022
2023Dec 2023
2024Dec 2024
2025Dec 2025
Net Sales
203,785152,339158,344169,278179,182
Cost of Sales
121,45189,87094,719100,309104,448
Gross Profit
82,33462,46863,62468,96874,733
SG&A Expenses
71,66655,03457,25462,54366,645
Operating Income
10,6677,4346,3706,4258,087
Non-operating Income
7597478181,0431,060
Non-operating Expenses
6547396105254
Ordinary Income
11,3628,1336,7917,3648,893
Extraordinary Income
153401245398
Extraordinary Losses
5531162401,4621,216
Pre-tax Income
10,9638,0576,5635,9468,075
Income Taxes
3,5362,4172,1532,1532,483
Net Income
7,1425,3034,1023,4755,238
EBITDA
16,03911,71510,60710,99512,841
Gross Margin
40.4%41.0%40.2%40.7%41.7%
Operating Margin
5.2%4.9%4.0%3.8%4.5%
ROA
5.9%4.3%3.1%2.6%3.5%
ROE
12.4%8.6%6.3%5.1%7.3%
Segment Performance
Unit: ¥M
2026
SegmentNet SalesOperating IncomeOperating Margin
家庭用品事業145,2636,5014.5%
総合環境衛生事業33,9181,5304.5%